{"title": "Awareness, Knowledge, and Vaccination Status of Meningococcal Meningitis Vaccination: A Comparative Study on International and Korean University Students", "author": "Shin; Kyung Suk; Sun; Hwa Yeon; Kwak; David Samuel; Yoo; Byung Wook", "url": "http://www.koreamed.org/SearchBasic.php?RID=2534136", "hostname": "koreamed.org", "description": "Meningitis; Meningococcus; Awareness; Vaccination; Communicable diseases", "sitename": "KoreaMed", "date": "2022-10-13", "cleaned_text": "2. Pelton SI. The global evolution of meningococcal epidemiology following the introduction of meningococcal vaccines. J Adolesc Health. 2016; 56(2 Suppl):S3-11. [Article](https://doi.org/10.1016/j.jadohealth.2016.04.012) 3. Wang B, Santoreneos R, Afzali H, Giles L, Marshall H. Costs of invasive meningococcal disease: a global systematic review. Pharmacoeconomics. 2018; 36(10):1201-22. [Article](https://doi.org/10.1007/s40273-018-0679-5) 4. Clinical practice guidelines for the management of bacterial meningitis in adults in Korea. Infect Chemother. 2012; 44(3):140-63. B, Bj\u00f6rnsson Gudmundsson S. Acute bacterial meningitis in adults. A 20-year overview. Arch Intern Med. 1997; 157(4):425-30. [Article](https://doi.org/10.1001/archinte.157.4.425) 7. McIntyre PB, O'Brien KL, Greenwood B, van de Beek D. Effect of vaccines on bacterial meningitis worldwide. Lancet. 2012; 380(9854):1703-11. [Article](https://doi.org/10.1016/s0140-6736(12)61187-8) 8. Guedes S, Bertrand-Gerentes I, Evans K, Coste F, Oster P. Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature. BMC Public of 4CMenB in preventing meningococcal real-world experience. Arch Dis Child. 2020; [Article](https://doi.org/10.1136/archdischild-2019-318047) 13. Lee SO, Ryu J, Woo JH, Kim YS. Meningococcal disease in the Republic of Korea army: incidence and serogroups determined by PCR. J Korean Med Sci. 2003; 18(2):163-6. [Article](https://doi.org/10.3346/jkms.2003.18.2.163) 14. Korea Disease Control and Prevention Agency (KCDA). 2018 guidelines for adult immunization. 2nd ed. Cheongju: KCDA;2018. p. 26. 15. Pollard AJ. Global epidemiology of meningococcal disease and vaccine efficacy. Pediatr Infect Dis J. 2004; 23(12 Suppl):S274-9. [Article](https://doi.org/10.1097/01.inf.0000147642.85129.05) 16. Mbaeyi SA, Joseph SJ, Blain A, Wang X, Hariri S, MacNeil JR. Meningococcal among college-aged young Capparella JM, Shutt KA, Perkins BA, Collins M. Risk factors for meningococcal disease in college students. JAMA. 2001; 286(6):688-93. [Article](https://doi.org/10.1001/jama.286.6.688) 18. Rosenstein N, Evans D, Plikaytis BD, Wenger JD, et al. Efficacy of vaccination. JAMA. 1998; Suppl [Article](https://doi.org/10.1016/j.vaccine.2007.04.049) JC, Ruitenberg for optimisation of immunisation strategies targeting invasive meningococcal disease in the Netherlands. Int J Health Policy Manag. 2015; 4(11):757-61. [Article](https://doi.org/10.15171/ijhpm.2015.168) 21. Lee SY, Han MA, Park J, Ryu SY. Factors associated with human papillomavirus vaccination and intention among male and female college students. Korean J Health Promot. 2015; 15(3):141-9. [Article](https://doi.org/10.15384/kjhp.2015.15.3.141) 22. Viner RM, Booy R, Johnson H, Edmunds WJ, Hudson L, Bedford H, et al. Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): infectious disease. Infect 2016; [Article](https://doi.org/10.3947/ic.2016.48.1.51) C, Ricci S, et al. Underestimation of invasive meningococcal disease in Italy. Emerg Infect Dis. 2016; 22(3):469-75. [Article](https://doi.org/10.3201/eid2203.150928) 26. Goodman AL, Masuet-Aumatell C, Halbert J, Zuckerman JN. Awareness of meningococcal disease among travelers from the United Kingdom to the meningitis belt in Africa. Am J "}